+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Mood Stabilizer"

From
Quetiapine Fumarate Tablets Market - Global Forecast 2025-2030 - Product Thumbnail Image

Quetiapine Fumarate Tablets Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 183 Pages
  • Global
From
Schizophrenia Therapeutics Market - Global Forecast 2025-2030 - Product Thumbnail Image

Schizophrenia Therapeutics Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 189 Pages
  • Global
From
From
Post-Traumatic Stress Disorder Therapeutics Market Report 2025 - Product Thumbnail Image

Post-Traumatic Stress Disorder Therapeutics Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Olanzapine Market Report 2025 - Product Thumbnail Image

Olanzapine Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Bipolar Disorder Drugs and Treatment Market Report 2025 - Product Thumbnail Image

Bipolar Disorder Drugs and Treatment Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Anxiety Disorders and Depression Treatment Market Report 2025 - Product Thumbnail Image

Anxiety Disorders and Depression Treatment Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Bipolar Disorder Therapeutics Market Report 2025 - Product Thumbnail Image

Bipolar Disorder Therapeutics Market Report 2025

  • Report
  • January 2025
  • 200 Pages
  • Global
From
From
Bipolar Disorder (Manic Depression)- Pipeline Insight, 2025 - Product Thumbnail Image

Bipolar Disorder (Manic Depression)- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Schizoaffective Disorder - Pipeline Insight, 2025 - Product Thumbnail Image

Schizoaffective Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Bipolar Disorder Treatment - Global Strategic Business Report - Product Thumbnail Image

Bipolar Disorder Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 387 Pages
  • Global
From
Bipolar Disorder Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Bipolar Disorder Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 380 Pages
  • Global
From
Bipolar Depression - Pipeline Insight, 2025 - Product Thumbnail Image

Bipolar Depression - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Treatment Resistant Depression Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Treatment Resistant Depression Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
From
Loading Indicator

Mood stabilizers are a class of drugs used to treat mental disorders, such as bipolar disorder, depression, and anxiety. These drugs work by regulating the levels of neurotransmitters in the brain, which can help to reduce the intensity of mood swings and other symptoms associated with mental disorders. Commonly prescribed mood stabilizers include lithium, valproic acid, carbamazepine, and lamotrigine. Mood stabilizers are an important part of the mental disorders drugs market, as they can help to reduce the severity of symptoms and improve quality of life for those affected. They are often used in combination with other medications, such as antidepressants, to provide a comprehensive treatment plan. Some of the companies in the mood stabilizer market include AbbVie, AstraZeneca, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, and Teva Pharmaceuticals. Show Less Read more